As of December 31, 2024, MyCelx Technologies Corp. carries a market capitalization of 889.28M, placing it among publicly traded companies globally. Its enterprise value stands at 889.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 889.28M |
| Enterprise Value | 889.04M |
MyCelx Technologies Corp.'s next confirmed earnings release is scheduled for May 20, 2027.
| Earnings Date | 5/20/2027 |
As of December 31, 2024, MyCelx Technologies Corp. has 24.36M shares outstanding.
| Shares Outstanding | 24.36M |
These figures are as of December 31, 2024.
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.44 |
As of December 31, 2024, MyCelx Technologies Corp. maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.84 |
| Quick Ratio | 0.32 |
| Debt / Equity | 23.88 |
As of the close on October 22, 2026, MyCelx Technologies Corp.'s stock has gained approximately 73.21% over the past 52 weeks. The 50-day moving average sits at 51.95, while the 200-day moving average is 50.61.
| 52-Week Price Change | 73.21% |
| 50-Day Moving Average | 51.95 |
| 200-Day Moving Average | 50.61 |
As of December 31, 2024, MyCelx Technologies Corp. holds 100.69M in cash and equivalents against 100.45M in total debt, resulting in a net debt position of -100.69M. Total book value stands at 420.56M, with working capital of 261.54M providing operational flexibility.
| Cash & Cash Equivalents | 100.69M |
| Total Debt | 100.45M |
| Net Debt | -100.69M |
| Equity (Book Value) | 420.56M |
| Book Value Per Share | 17.26 |
| Working Capital | 261.54M |